AbbVie Lifts Profit Outlook as Sales Rise

AbbVie ABBV 1.36%increase; green up pointing triangle raised its full-year adjusted earnings outlook, even though profit was pressured by increased expenses during the third quarter.

The North Chicago, Ill., drugmaker on Friday said it now expects adjusted earnings of $10.61 to $10.65 a share for the year, up from a prior outlook of $10.38 to $10.58 a share. Analysts surveyed by FactSet are looking for adjusted earnings of $10.51 a share.